Herbert Alexander, MD
Dermatology · Johns Creek, GANPI 1093992588
Payments from drug & device makers
Across 268 payments — averaging $21.06 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$1K
- LEO Pharma Inc.$615
- Johnson & Johnson$479
- Sanofi$454
- Galderma Laboratories, L.p.$398
- Incyte Corporation$326
- plus $2K from 24 others
What the payments were for
- Food & beverage$5,25593%
- Education$3907%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 68 | $1,292 |
| LEO Pharma Inc. | 38 | $615 |
| Johnson & Johnson | 12 | $479 |
| Sanofi | 14 | $454 |
| Galderma Laboratories, L.p. | 24 | $398 |
| Incyte Corporation | 16 | $326 |
| Ortho Dermatologics, A Division Of Bausch Health US, LLC | 17 | $323 |
| Almirall LLC | 12 | $234 |
| Regeneron Healthcare Solutions, Inc. | 9 | $206 |
| UCB, Inc. | 9 | $184 |
| Pfizer | 8 | $165 |
| Arcutis Biotherapeutics, Inc. | 4 | $163 |
| Sun Pharmaceutical Industries Inc. | 6 | $105 |
| Sanofi-aventis U.S. LLC | 1 | $95 |
| Amgen | 4 | $92 |
| E.r. Squibb & Sons, L.L.C. | 3 | $68 |
| Novartis | 2 | $64 |
| VYNE Pharmaceuticals Inc. | 3 | $62 |
| Mayne Pharma Commercial LLC | 3 | $54 |
| Merz North America, Inc. | 2 | $48 |
| Sandoz | 2 | $38 |
| EPI Health, LLC | 2 | $35 |
| Botanix SB Inc | 2 | $35 |
| Boehringer Ingelheim | 1 | $23 |
| Fidia Pharma USA Inc. | 1 | $18 |
| Bristol Myers Squibb | 1 | $16 |
| Mylan Pharmaceuticals Inc. | 1 | $15 |
| Lilly USA, LLC | 1 | $14 |
| Dermavant Sciences, Inc. | 1 | $13 |
| Merck | 1 | $11 |
How this compares
$5,645 in reported general payments places this provider in the 55th percentile of 345 dermatology providers in Georgia.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Clobetasol Propionate | 32 | $1,353 |
| Fluorouracil | 16 | $1,069 |
| ValacyclovirValacyclovir Hcl | 25 | $1,022 |
| Fluocinonide | 27 | $1,007 |
| Triamcinolone Acetonide | 62 | $752 |
| Imiquimod | 27 | $697 |
| Hydrocortisone | 54 | $605 |
| Doxycycline Hyclate | 27 | $347 |
| Minoxidil | 25 | $277 |
| Econazole Nitrate | 13 | $164 |
| Mupirocin | 19 | $163 |
| Prednisone | 30 | $98 |
Paid to pharmacies, not to this prescriber.
Other dermatology in Johns Creek
- David CohenMacon$5.5M
- Jamie WeismanAtlanta$4.9M
- Tiffani HamiltonAlpharetta$3.3M
- Firas HougeirDouglasville$3.3M
- Jonathan WeissSnellville$2.4M
- Mark KnautzPowder Springs$1.7M
- Gerald SlagelFayetteville$1.2M
- Zakiya RiceAtlanta$1.1M
- Corinne HowingtonSavannah$874K
- Alia BrownSnellville$838K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.